Abbott gets FDA approval for first smartphone compatible insertable cardiac monitor Ruby Khatun Khatun25 Oct 2017 10:00 AM ISTAbbott has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first and only...
Lumenis launches its first ever M22 OPT technology for dry and itchy eyes caused by eyelid inflammation Ruby Khatun Khatun16 Oct 2017 10:07 AM ISTNew Delhi: With an increasing use of gadgets like mobiles phones, laptops and computers workaholic people are more prone to dry eye syndrome. Studies...
Apollo Hospitals joins hands with Samsung to fight non-communicable diseases in India Ruby Khatun Khatun15 Oct 2017 10:35 AM ISTChennai: Samsung India, India’s biggest and most trusted consumer electronics and mobile phones brand, and Apollo Hospitals, Asia’s largest and most...
Lupin acquires Symbiomix Therapeutics for 150 million dollars Ruby Khatun Khatun13 Oct 2017 12:34 PM ISTMumbai: Pharma major Lupin announced that its US subsidiary, Lupin, Inc., has acquired Symbiomix Therapeutics, LLC.Lupin had entered into an option to...
LifeCell ties-up with Cryo-Save India for preserved umbilical cord stem cell samples Ruby Khatun Khatun11 Oct 2017 9:58 AM ISTChennai: LifeCell announced the signing of a formal agreement with Cryo-Save India (Cryo-Save) for the formal transfer of all of its 18,000...
Indias first global consortium to unveil collective diagnostic strength of four countries Ruby Khatun Khatun10 Oct 2017 10:30 AM ISTBangalore: Aggregating the fragmented diagnostic sector of the country, four nations joined forces to launch India’s first global Pathology Laboratory...
Gilead Sciences completes acquisition of Kite Pharma in 11.9 billion dollar Ruby Khatun Khatun7 Oct 2017 10:00 AM ISTFOSTER CITY, Calif.: Gilead Sciences, Inc. announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
SMT launches next generation Supralimus Grace drug eluting stent in India Ruby Khatun Khatun1 Oct 2017 11:15 AM ISTMumbai: SMT, One of the largest stent manufacturing company in India, has recently announced the launch and widespread availability plans for its...
MD Anderson, Pfizer announce immuno-oncology collaboration Ruby Khatun Khatun30 Sept 2017 9:35 AM ISTThe University of Texas MD Anderson Cancer Center and Pfizer Inc. announced that they have entered into a clinical collaboration to study novel...
Sanofi , Innovation Health Announces Pilot Program to Improve Care Delivery inType 2 Diabetes supriya kashyap kashyap28 Sept 2017 9:16 AM ISTFalls Church: Innovation Health, a unique partnership between two industry leaders, Inova and Aetna, and Sanofi, a global healthcare leader, announced...
Perrigo gets FDA final approval for generic version of Exalgo® 32mg extended release tablets Ruby Khatun Khatun26 Sept 2017 9:51 AM ISTDUBLIN: Perrigo Company plc announced it has received final approval from the U.S. Food and Drug Administration (FDA) for its AB-rated Abbreviated New...
